A Third Dimension Bioseeker Jun 2026

Portable bio-spatial scanner for detecting, mapping, and interacting with hidden 3D biological structures — including subsurface, intracellular, or interdimensional biomass.

The "BioSeeker" component of the technology refers to the active search for biological signals—mutations, transcripts, proteins—within a preserved spatial context. The "Third Dimension" denotes the addition of volumetric depth, converting a 2D slide into a 3D digital twin of the living tissue. a third dimension bioseeker

Checkpoint inhibitors (like Keytruda or Opdivo) fail in 60-70% of solid tumors. Why? Flat sequencing often shows the tumor has the target antigen, but the BioSeeker reveals the third dimension: T-cells are clustering on the periphery of the tumor, unable to penetrate the dense core. By visualizing the depth of immune exclusion, oncologists can now predict non-response before treatment begins. Checkpoint inhibitors (like Keytruda or Opdivo) fail in

The process begins by fixing the biological sample (e.g., a biopsy or organoid) and infusing it with a hydrogel polymer. This creates a tough, transparent scaffold that holds every RNA and DNA molecule in its exact original location. By visualizing the depth of immune exclusion, oncologists

: It powers modular systems for fast, accessible molecular diagnostics in the field. 🌐 The "Third Dimension" Framework